One of the assets shelved by Eli Lilly is a gene therapy for dementia, which it obtained in its $1.04-billion acquisition of Prevail Therapeutics in late 2020.
Sourcing Journal on MSN
LaundRe is reviving UK denim, one jean at a time
In London's Docklands, a sustainable denim finishing company is turning today's written-off stock into tomorrow's latest ...
There has been no indication of any leaks, officials said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results